Mesothelioma treatment options include surgery, chemotherapy, immunotherapy, radiation and care aimed at easing symptoms. The right plan depends on where the cancer began, how far it has spread, its cell type, a person’s overall health and goals. Specialists may combine treatments rather than rely on one approach.
Key Takeaways
- Treatment choices depend on the cancer’s location, cell type and extent, as well as the person’s health and preferences.
- Options can include surgery, chemotherapy, immunotherapy, radiation and supportive care.
- Surgery is appropriate only for some people. Its potential benefits and risks need careful discussion.
- Supportive care can help manage symptoms and improve quality of life at any point in treatment.
- A second opinion or a clinical trial may help patients understand their choices.
Mesothelioma treatment options depend on type and extent
Mesothelioma is a cancer that develops in the thin layer of tissue covering certain organs. It most often affects the lining around the lungs, called the pleura, or the lining inside the abdomen, called the peritoneum. Asbestos exposure is the main established risk factor, but not everyone with mesothelioma has a known exposure history.
Before recommending treatment, clinicians confirm the diagnosis and assess how far the disease has spread. Imaging tests can show where tumors are and whether nearby areas may be involved. A biopsy, in which a small tissue sample is examined, is usually needed to confirm mesothelioma and identify its cell type. Cancer care guidance from major health authorities emphasizes using these findings, alongside a person’s overall health and preferences, to shape the plan.
Doctors may discuss whether the cancer appears operable, meaning surgery could remove visible disease, and whether treatment is intended to control the cancer, relieve symptoms, or both. A team may include cancer specialists, surgeons, radiologists, nurses and palliative care professionals.
Which treatments may be used?
Surgery
Surgery may be considered for selected patients, particularly when the cancer is confined enough for an operation and the person is fit for it. For pleural mesothelioma, operations may remove the lining around the lung and visible tumor. Some procedures also remove the lung. These are major operations, and the possible benefits, recovery and risks vary. Surgery is not suitable for everyone, and its role should be discussed with an experienced mesothelioma team.
For some people with peritoneal mesothelioma, surgeons may remove visible tumor and use heated chemotherapy inside the abdomen. This approach is called cytoreductive surgery with heated intraperitoneal chemotherapy, or HIPEC. It is a complex treatment for carefully selected patients, not a standard choice for everyone.
Chemotherapy
Chemotherapy uses medicines to kill cancer cells or slow their growth. It may be used on its own, before or after surgery, or alongside other treatment. The medicines and schedule depend on the diagnosis and the person’s health. Side effects can include fatigue, nausea and changes in blood counts. The care team can explain ways to monitor and manage them.
Immunotherapy
Immunotherapy helps the body’s immune system recognize and attack cancer. It is an option for some people with mesothelioma, including some with pleural disease. Whether it is appropriate depends on factors such as the cancer’s type, earlier treatment and the person’s medical history. Immune related side effects can affect different organs, so new or worsening symptoms should be reported to the care team.
Radiation and supportive care
Radiation uses focused energy to treat a specific area. It may be used to help control symptoms or as part of a broader treatment plan. Its purpose and likely effects depend on the area treated.
Supportive care, also called palliative care, focuses on easing symptoms and supporting quality of life. It can help with pain, breathlessness, appetite concerns, fatigue and emotional strain. It can be provided alongside cancer treatment and does not mean that active treatment has stopped.
How care differs by mesothelioma type
Pleural and peritoneal mesothelioma do not always follow the same treatment path. For pleural disease, clinicians may consider systemic treatment, which travels through the bloodstream, as well as surgery or radiation for selected patients. For peritoneal disease, treatment may involve systemic medicines, surgery with HIPEC for some patients, or symptom focused care.
The cancer’s cell type also matters. Mesothelioma can have different patterns of cancer cells, and these patterns can influence how the disease behaves and which treatments are considered. A specialist can explain what the biopsy shows and how it affects the options.
Clinical trials are research studies that test new treatments or new ways to use existing ones. Availability and eligibility vary. Asking the care team whether a trial is appropriate can help patients understand whether there is a study suited to their diagnosis and circumstances.
How can patients weigh the choices?
Ask the treatment team to explain the goal of each option, the expected benefits, the main risks and how treatment may affect daily life. It can also help to ask how the choices compare, what may happen if treatment is delayed or not chosen, and how symptoms will be managed.
A second opinion from a clinician experienced in mesothelioma can offer another perspective, especially before a major operation. Patients may bring a trusted person to appointments, take notes and request copies of test results. The best plan is one that reflects the medical evidence and the patient’s priorities, with room to revisit decisions as needs change.